In summary, we revealed that BCI inhibited RANKL-mediated osteoclastogenesis by restraining STAT3 activity and NF-κB–NFATc1 signaling in vitro and ameliorating OVX-induced osteoporosis in vivo. This evidence concerns the gene TNFSF11 and osteoporosis.